See all Best Industrial Instruments Stocks 2026

DHR Stock Analysis: Buy, Sell, or Hold?

DHR - Danaher Corporation

INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
$204.76
4.78 (2.39%) ▲
5d: +5.02%
30d: +4.48%
90d: +16.57%
WAIT
LOW Confidence
Protect Your DHR Gains
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal last confirmed Aug 7, 2026

Strength: 3.4/10

Get Alerted When DHR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: DHR shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$287.17
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$178.31
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.4x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: DHR is currently trading at $204.76, which is considered extended relative to its 30-day fair value range of $189.89 to $201.86. The stock's valuation (Forward PE: 22.0) is in line with its historical norms (22.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This pessimistic expectation contrasts with the company's recent 59.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, DHR is in a strong uptrend. The price is approaching resistance at $209.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: DHR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $227.96 (+11.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $189.89 - $201.86
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 26.2%

Protect Your Profits

Holding DHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($227.96)
  • WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $189.89 - $201.86
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $189.85
Resistance Level $209.90
Current Trend Strong Uptrend
Technical data as of Aug 7, 2026

Fundamental Context

Forward P/E (Next Year Est.) 22.02
Wall Street Target $227.96 (+11.3%)
Revenue Growth (YoY) 5.5%
Earnings Growth (YoY) 59.7%
Profit Margin 16.0%
Valuation Discount vs History -0.6% cheaper
PE vs Historical 22.0 vs 22.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -0.6% (market-implied from PE analysis)
1-Year Target $203.53 (-1%)
2-Year Target $202.31 (-1%)
3-Year Target $201.10 (-2%)
3-Yr Target (if PE normalizes) (PE: 22→22) $204.57 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.0, Growth: 9.3%) $267.22 (+31%)
Base: (SPY PE: 20.2, Growth: 9.3%) $245.50 (+20%)
Bear: (PE: 17.2, Growth: 9.3%) $208.68 (+2%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Trailing PE: 35.65 | Current EPS (TTM): $5.61
Bull Case $364.62 (+78%)
Analyst growth 65.8%, PE expands to 39.2
Base Case $331.48 (+62%)
Market implied 65.8%, PE stable at 35.7
Bear Case $135.99 (-34%)
Severe decline -20.0%, PE contracts to 30.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.0 to 22.4
Stabilization Target: $208.29 (+1.7%)
PE Expansion Potential: +1.7%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 08, 2026 5:31 PM ET
Data refreshes hourly during market hours. Next update: 6:31 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is DHR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna SELL 2026-03-23
Ro Khanna BUY 2026-03-10
Ro Khanna SELL 2026-02-24

Unlock Insider Activity

See real-time buying/selling by company executives for DHR.

Create Free Account

Already have an account? Log In

Featured in Portfolios

DHR is a key holding in these high-performance investment strategies.

Healthcare Giants Sector • +15.7% Return
53
View All Strategies

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientific… 		STRONG BUY
31 analysts 		$630 42 HOLD
EXAS
EXACT Sciences Corporati… 		STRONG BUY
26 analysts 		$106 52 HOLD
GH
Guardant Health Inc 		STRONG BUY
23 analysts 		$188 37 SELL
NTRA
Natera Inc 		STRONG BUY
21 analysts 		$283 39 SELL
IQV
IQVIA Holdings Inc 		BUY
23 analysts 		$273 35 SELL
TMO Thermo Fisher Sci…
42 HOLD
EXAS EXACT Sciences Co…
52 HOLD
GH Guardant Health I…
37 SELL
NTRA Natera Inc
39 SELL
IQV IQVIA Holdings Inc
35 SELL

Advanced DHR Option Strategies

Professional options setups generated by AI based on today's DHR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for DHR

DHR Technical Chart DHR Price Prediction DHR Earnings Date DHR Investment Advisor DHR Fair Price Analyzer DHR Options Advisor DHR Options Chain DHR Options Analysis DHR Competitors
Compare DHR with Peers
DHR vs TMO
Which one to buy?
DHR vs SYK
Which one to buy?
DHR vs BDX
Which one to buy?
DHR vs ZTS
Which one to buy?
DHR vs ECL
Which one to buy?
DHR vs SYPR
Winner: DHR
DHR vs TMO
DHR vs SYK
AME vs DHR
ZTS vs DHR
Winner: DHR
ELSE vs DHR
DHR vs RAL
Winner: DHR
DHR vs KEYS
MKSI vs DHR
DHR vs ROP
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals